A Study of Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer

NCT02595762 · clinicaltrials.gov ↗

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer
Locally Advanced Breast Cancer

Sponsor

Hoffmann-La Roche